ALDR

Alder Biopharmaceuticals, Inc.
ALDR

Overview Fund Activity
Delisted

ALDR was delisted on the 21st of October, 2019.

Back to rankings

75 hedge funds and large institutions have $383M invested in Alder Biopharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 22 increasing their positions, 25 reducing their positions, and 3 closing their positions.

Holders
75
Holders Change
+18
Holders Change %
+31.58%
% of All Funds
2%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
21
Increased
22
Reduced
25
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$12.2M
2
BFA
2
BlackRock Fund Advisors
California
$17M
3
FCMI
3
Foresite Capital Management II
California
$7.13M
4
NLVP
4
New Leaf Venture Partners
New York
$6.5M
5
Goldman Sachs
5
Goldman Sachs
New York
$6.18M

Top Sellers

1
PHS
1
PFM Health Sciences
California
$9.6M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$10.7M
3
PC
3
PointState Capital
New York
$5.09M
4
Jennison Associates
4
Jennison Associates
New York
$34.4M
5
Millennium Management
5
Millennium Management
New York
$449K
Name Market Value Shares Shares
Change 		Shares
Change %
Deutsche Bank
76
Deutsche Bank
Germany
$0 34 -10,210 -100%
BNP Paribas Financial Markets
77
BNP Paribas Financial Markets
France
– – -452 Closed
PNC Financial Services Group
78
PNC Financial Services Group
Pennsylvania
$0 8 +8 New
1 2 3
4